Total Payments
$1,345
2022 Payments
$58.53
Companies
16
Transactions
59
Medicare Patients
1,989
Medicare Billing
$256,417
Payment Breakdown by Category
Food & Beverage$1,205 (89.6%)
Education$139.98 (10.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,205 | 57 | 89.6% |
| Education | $139.98 | 2 | 10.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $555.52 | 26 | $0 (2022) |
| Astellas Pharma US Inc | $203.51 | 6 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $117.36 | 1 | $0 (2017) |
| AbbVie Inc. | $90.30 | 1 | $0 (2021) |
| Novo Nordisk Inc | $59.33 | 4 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $54.53 | 3 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $51.22 | 3 | $0 (2020) |
| GlaxoSmithKline, LLC. | $50.38 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $38.58 | 3 | $0 (2022) |
| Amarin Pharma Inc. | $30.89 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $58.53 | 3 | GlaxoSmithKline, LLC. ($21.38) |
| 2021 | $194.89 | 7 | AbbVie Inc. ($90.30) |
| 2020 | $158.69 | 7 | Astellas Pharma US Inc ($64.99) |
| 2019 | $495.24 | 25 | Amgen Inc. ($354.78) |
| 2018 | $114.03 | 7 | Amgen Inc. ($51.23) |
| 2017 | $323.38 | 10 | AstraZeneca Pharmaceuticals LP ($117.36) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/02/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Inflammation | ||||||
| 03/01/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: VACCINES | ||||||
| 02/01/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/09/2021 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $11.73 | General |
| 10/21/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $90.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Cardiology | ||||||
| 06/15/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Bone Health | ||||||
| 02/08/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Inflammation | ||||||
| 02/02/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Bone Health | ||||||
| 12/01/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $64.99 | General |
| 11/09/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2020 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Inflammation | ||||||
| 09/17/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Bone Health | ||||||
| 09/16/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/20/2020 | Smith+Nephew, Inc. | Santyl (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Pharma Product | ||||||
| 12/05/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiology | ||||||
| 11/20/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: Bone Health | ||||||
| 11/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/01/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Cardiology | ||||||
| 10/31/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: UROLOGY | ||||||
| 10/22/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.39 | General |
| 10/18/2019 | VIVUS, Inc. | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/18/2019 | VIVUS, Inc. | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 11 | 421 | 1,347 | $81,331 | $49,247 |
| 2021 | 17 | 770 | 2,644 | $176,683 | $119,608 |
| 2020 | 13 | 798 | 1,515 | $148,085 | $87,562 |
Total Patients
1,989
Total Services
5,506
Medicare Billing
$256,417
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 224 | $24,736 | $14,902 | 60.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 780 | $27,300 | $13,202 | 48.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 60 | 60 | $9,420 | $8,132 | 86.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 51 | 65 | $10,240 | $7,201 | 70.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 34 | $3,607 | $2,876 | 79.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 35 | $1,617 | $1,003 | 62.0% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 12 | 13 | $1,042 | $778.33 | 74.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 16 | $1,218 | $645.85 | 53.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 52 | 67 | $1,005 | $200.16 | 19.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $277.12 | $156.35 | 56.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 25 | 37 | $868.02 | $150.05 | 17.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 199 | 535 | $59,080 | $41,966 | 71.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 14 | 1,260 | $44,100 | $20,878 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 135 | 135 | $20,066 | $18,007 | 89.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 88 | 137 | $21,242 | $14,992 | 70.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 70 | $7,427 | $5,942 | 80.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 17 | 19 | $4,711 | $3,606 | 76.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 17 | $3,503 | $2,803 | 80.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 44 | 76 | $3,510 | $2,550 | 72.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 13 | 13 | $2,287 | $2,249 | 98.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 25 | $1,904 | $1,441 | 75.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 27 | 34 | $1,840 | $1,386 | 75.3% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 13 | 20 | $1,602 | $1,172 | 73.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 36 | 47 | $814.04 | $562.05 | 69.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 59 | $851.96 | $554.40 | 65.1% |
About Dr. Robert Collins, MD
Dr. Robert Collins, MD is a Internal Medicine healthcare provider based in Palm Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275547697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Collins, MD has received a total of $1,345 in payments from pharmaceutical and medical device companies, with $58.53 received in 2022. These payments were reported across 59 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,205).
As a Medicare-enrolled provider, Collins has provided services to 1,989 Medicare beneficiaries, totaling 5,506 services with total Medicare billing of $256,417. Data is available for 3 years (2020–2022), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Palm Springs, FL
- Active Since 07/28/2006
- Last Updated 04/23/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1275547697
Products in Payments
- EVENITY (Biological) $207.27
- Repatha (Biological) $183.02
- BEVESPI AEROSPHERE (Drug) $117.36
- UBRELVY (Drug) $103.19
- Aimovig (Biological) $64.12
- PRALUENT (Drug) $54.53
- Otezla (Drug) $54.02
- Prolia (Biological) $47.09
- XARELTO (Drug) $36.86
- MYRBETRIQ (Drug) $34.61
- Vascepa (Drug) $30.89
- Myrbetriq (Drug) $28.92
- Saxenda (Drug) $27.57
- ENTRESTO (Drug) $26.85
- SHINGRIX (Biological) $21.38
- TRINTELLIX (Drug) $20.09
- QSYMIA (Drug) $18.16
- Santyl (Drug) $17.79
- SHINGRIX (Drug) $17.15
- INVOKANA (Drug) $14.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Palm Springs
Michael Jardula, Md, MD
Internal Medicine — Payments: $68,805
Internal Medicine $68,805
Michael Bagheri, Md, MD
Internal Medicine — Payments: $37,109
Internal Medicine $37,109
Ann Stapleton, Md, MD
Internal Medicine — Payments: $34,455
Internal Medicine $34,455
Elber Camacho, Md, MD
Internal Medicine — Payments: $21,044
Internal Medicine $21,044
Dr. Dimple Agarwal, M.d, M.D
Internal Medicine — Payments: $18,144
Internal Medicine $18,144
Xolani Mdluli, Md, MD
Internal Medicine — Payments: $10,234
Internal Medicine $10,234